A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity
Status:
Recruiting
Trial end date:
2023-01-12
Target enrollment:
Participant gender:
Summary
The study is looking at a new medicine to help people lose weight. In this study participants
will either get semaglutide and NNC0165-1875 or semaglutide and a "dummy" medicine (placebo).
Which treatment participants get is decided by chance. Participants will get 2 injections per
week, on the same day. Participants will have to take the study medicine by use of a
pre-filled pen. A pen is a medical tool with a needle used for injections under the skin. The
study doctor or staff will show participants how. The study will last for about 26 weeks.
Participants will have 17 visits at the clinic with the study doctor. At 4 of the clinic
visits participants cannot eat and drink (water is allowed until 2 hours prior to the visit)
for 8 hours before the visit.Women: Women cannot take part if pregnant, breast-feeding or
plan to become pregnant during the study period. Women who are able to become pregnant can
participate if they agree to use contraception during the study.